Medical Center for Cancer & Blood Disorders
The Center for Cancer and Blood Disorders at Phoenix Children's Hospital is the largest pediatric program of its kind in Arizona, providing complete care for children diagnosed with malignancies and/or life-threatening hematologic diseases.
Using a family-centered approach, the Center provides comprehensive, personalized care to every hematology and oncology patient. Every child has his or her own team of physicians, nurses, social workers, physical therapists, nutritionists and more that provide care throughout the treatment and healing process. The team works to make sure that the care regimen fits in with the child's – and the family's – needs.
The Center's team of medical practitioners includes many specialists, each with a specific area of expertise within the hematology and oncology fields. Encouraging each provider to specialize in certain diseases has allowed the Center's team to collectively keep up with the latest advancements in the treatment of cancer and hematologic disorders. As a result, the Center is able to provide top-notch, cutting edge care to all of its patients.
Phoenix Children's has the largest pediatric cancer program in Arizona and is a leading participant in research to find cures for childhood cancer. The Hospital is a long-standing member of Children's Oncology Group (COG), a national research consortium, and one of three COG members in the state. Phoenix Children's is one of two institutions in Arizona – and the only location in Phoenix – conducting Phase I trials, giving pediatric cancer patients access to the newest treatments available. The Oncology Program is also an active participant in the Pediatric Oncology Experimental Therapeutic Investigator Consortium (POETIC), a Phase I consortium composed of 10 large academic medical centers in the United States and Canada.
Phoenix Children's Hemophilia Center is the largest program of its kind in Arizona and is making significant difference in the quality of life for pediatric and adult hemophilia patients. It is one of only two federally funded hemophilia treatment programs in the state. The Center treats children with sickle cell disease, hemophilia and other hematologic disorders.
Ottosen Family Blood and Marrow Transplant Program
Phoenix Children's Hospital and Mayo Clinic in Scottsdale run the Valley's only accredited pediatric blood and marrow transplant (BMT) program. This program fills a critical gap in area services because, previously, the only pediatric BMT program in the state of Arizona was at University Medical Center in Tucson. This meant that families in the Valley, already struggling with the burden of having a child with cancer, had to face the additional stress and inconvenience of having a child hospitalized in a distant facility outside of Phoenix for several months.
The Jaydie Lynn King Neuro-oncology Program, treating brain and spinal cord tumors, is the only comprehensive pediatric neuro-oncology program in Arizona. Program providers work closely with a variety of sub-specialists and departments across the Hospital. The Neuro-Oncology Program treats more than 70 percent of brain tumor patients in Arizona. The Program also has the only fellowship trained clinical pediatric neuro-oncologist in the state. The Program is also a part of our Children’s Neuroscience Institute, combining the strengths and expertise of both Centers of Excellence.
Solid Tumor/Vascular Program
Phoenix Children's Solid Tumor Program is the only comprehensive program of its kind in Arizona. The program offers a multidisciplinary, disease-focused approach to the treatment of individual subtypes of tumors such as neuroblastomas, kidney tumors, liver tumors and sarcomas, offering the latest treatments for specific disease types. The program team also works in collaboration with the Division of Pediatric Dermatology to offer a comprehensive Vascular Malformation Clinic.
Liquid Tumor Program
The Liquid Tumor Program is the only comprehensive program in Arizona offering treatment expertise for children with acute lymphoblastic leukemia, acute myelogenous leukemia, lymphoma and histiocytosis. The program offers the most up-to-date clinical trials, research collaborations and evidence-based practices available to treat children diagnosed with a wide variety of liquid tumors.
Early Drug Development Program
This program evaluates the most promising new therapies for childhood cancer by offering phase I and II clinical trials and giving patients access to the most cutting-edge agents available.
Survivor/Long Term Follow-up Program
Phoenix Children's survivor program is the largest of its kind in Arizona. The program offers multidisciplinary care for survivors of childhood cancer, regardless of where the patient was originally treated. The team works collaboratively with primary care providers to develop recommendations for ongoing treatment and participates in hospital and nationally based research to provide the most advanced care for patients. The program also focuses on fertility preservation.
For more information, please visit any of the links below.
Candlelighters –Childhood Cancer Foundation
Phone: (602) 933-0290
Fax: (602) 933-0276